BTIS
VRTX icon

BB&T Investment Services’s Vertex Pharmaceuticals VRTX Stock Holding History

BB&T Investment Services’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$17K Buy
129
+28
+28% +$4.15K ﹤0.01% 853
2017
Q3 		$15K Buy
101
+95
+1,583% +$14.3K ﹤0.01% 777
2017
Q2 		$1K Sell
6
-4
-40% -$482 ﹤0.01% 1086
2017
Q1 		$0 Buy
10
+8
+400% +$704 ﹤0.01% 1114
2016
Q4 		$0 Buy
+2
New +$163 ﹤0.01% 800

Other funds holding VRTX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

BB&T Investment Services's VRTX Position: Q4 2017 in Review

BB&T Investment Services increased its Vertex Pharmaceuticals (VRTX) stake by 28% in Q4 2017, buying an estimated $4.15K and bringing the position to 129 shares worth $17K. The position accounts for ﹤0.01% of the portfolio, ranked #853.

BB&T Investment Services first reported a position in VRTX in Q4 2016 and has held it in 5 quarters since. 644 funds tracked by Wall St. Rank hold VRTX as of Q4 2017.

  • BB&T Investment Services held 129 shares of Vertex Pharmaceuticals worth $17K as of Q4 2017.
  • BB&T Investment Services bought 28 Vertex Pharmaceuticals shares in Q4 2017, an estimated $4.15K.
  • Vertex Pharmaceuticals made up ﹤0.01% of BB&T Investment Services's portfolio in Q4 2017, its #853 holding.
  • BB&T Investment Services first reported a position in Vertex Pharmaceuticals in Q4 2016 and has held it in 5 quarters since.
  • 644 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2017.

Based on BB&T Investment Services's 13F filing for Q4 2017, filed 15 Feb 2018.